Guangdong Jiaying Pharmaceutical Co (002198) Fair Value & Analysis
Healthcare · CN · Market cap 1.8B CNY
Fair value as of: Jun 25, 2026
Analysis
Guangdong Jiaying Pharmaceutical Co (002198) currently trades at ¥3.22, while our model-based Fair Value estimate is ¥1.18 — implying the stock looks roughly 63.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufeng Huoluo tablets, Tiaomeng Huoxue tablets, etc. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meizhou, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Guangdong Jiaying Pharmaceutical Co (002198) undervalued?
What is the fair value of 002198?
What is the quality score of 002198?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.